Superoxide is generated by reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase that exists in the cell membrane of neutrophils and contains p47 phox in the enzyme complex. Superoxide is closely related to various diseases, including infection, myocardial infarction, and aspiration pneumonia. Therefore we performed this study to establish how lidocaine acts on NADPH oxidase. We examined the effects of lidocaine on superoxide production in neutrophils using the method of 2-methyl-6-phenyl-3,7-dihydro [1,2-a] pyrazin-3-one (CLA phenyl)-dependent chemiluminescence activated by opsonized zymosan (OZ). Treatment with lidocaine 15 M suppressed OZactivated CLA phenyl-dependent chemiluminescence by approximately 40% compared with that of OZ onlyactivated neutrophils. It was further demonstrated that the suppressive effect of lidocaine on superoxide production was dependent on the concentration of lidocaine. Translocation of p47 phox from the cytosol to the cell membrane was studied using immunoblot analysis with a polyclonal anti-p47 phox antibody. Lidocaine suppressed OZ-induced p47 phox translocation in a dose-dependent manner. Our results suggest that suppression of superoxide production by a therapeutic dose of lidocaine correlates strongly with suppression of p47 phox translocation. (Anesth Analg 2001;93:1501-6) 
*Department of Anesthesiology and †Department of Biochemistry, School of Medicine, Nihon University, Tokyo, Japan Superoxide is generated by reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase that exists in the cell membrane of neutrophils and contains p47 phox in the enzyme complex. Superoxide is closely related to various diseases, including infection, myocardial infarction, and aspiration pneumonia. Therefore we performed this study to establish how lidocaine acts on NADPH oxidase. We examined the effects of lidocaine on superoxide production in neutrophils using the method of 2-methyl-6-phenyl-3,7-dihydro [1,2-a] pyrazin-3-one (CLA phenyl)-dependent chemiluminescence activated by opsonized zymosan (OZ). Treatment with lidocaine 15 M suppressed OZactivated CLA phenyl-dependent chemiluminescence by approximately 40% compared with that of OZ onlyactivated neutrophils. It was further demonstrated that the suppressive effect of lidocaine on superoxide production was dependent on the concentration of lidocaine. Translocation of p47 phox from the cytosol to the cell membrane was studied using immunoblot analysis with a polyclonal anti-p47 phox antibody. Lidocaine suppressed OZ-induced p47 phox translocation in a dose-dependent manner. Our results suggest that suppression of superoxide production by a therapeutic dose of lidocaine correlates strongly with suppression of p47 phox translocation. E pidural administration of local anesthetics is effective for relief of pain caused by malignancy and surgery. However, long-term infusion of local anesthetics may cause infectious complications. Recently, many reports have indicated the incidence of local infections arising from the use of epidural catheters to be approximately 4.3%-12% (1). Although it has not been clearly established how local anesthetics are associated with these complications, it has been reported that several kinds of local anesthetics suppressed the function of neutrophils (2, 3) . Previous studies have shown that local anesthetics inhibited superoxide generation in neutrophils that were activated by phorbol myristate acetate (PMA) (4, 5) .
There are several pathways to generate superoxide in neutrophils. PMA, a stimulant of protein kinase C, activates superoxide production in neutrophils, and this pathway is recognized as a non-phagocytic process. In contrast, opsonized zymosan (OZ), extract of yeast and incubated with healthy serum, stimulates Fc receptor-mediated phagocytosis by neutrophils in a similar way to bacteria (6) . Therefore, we used (OZ) as a stimulant of human neutrophils in this study.
Neutrophils are phagocytic cells that act as a part of the self-defense system against invading bacteria, through the release of superoxide anions (7). The superoxide anion is a powerful bactericidal agent, which is generated by nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase in the cell membrane of neutrophils. NADPH-oxidase is a complex enzyme system, which is assembled with both cytosolic factors, such as p47 phox, p67 phox, and rac 1, and a membrane factor, cytochrome b558, which is formed by two subunits of gp91 phox and p22 phox (8) . After activation by stimulants such as bacteria, lipopolysaccharides, or PMA, p47 phox is translocated from the cytosol to the cell membrane. After the translocation of p47 phox, p67 phox and rac 1 are able to bind successively to p47 phox and cytochrome b558 complex in the cell membrane (9) .
In the present study, we evaluated the effects of lidocaine on superoxide production of human neutrophils that were activated by OZ. Furthermore, we examined p47 phox translocation to establish a link between the reduction in superoxide production in the presence of lidocaine and the reduced translocation of p47 phox to the cell membrane in neutrophils stimulated with OZ.
Methods
Zymosan, cytochrome c, pepstatin, phenylmethylsulfonylfluoride, and superoxide dismutase were purchased from Sigma Chemical Co. Human neutrophils were isolated by the method of Chen et al. (10) . Briefly, venous blood from 3 healthy adult (31-48 yr) male donors was collected aseptically into a heparinized plastic syringe. Then 30 mL of blood was mixed with a solution of 20 mL of 2% dextran in 0.9% NaCl, and then left for 20 min at room temperature to sediment red blood cells. Subsequently, the neutrophil-rich fraction was carefully discharged from the plastic syringe and layered onto Ficoll-sodium iothalamate solution and centrifuged at 400g for 30 min. Hypotonic cell lysis in 0.2% NaCl was performed for 30 s to loosen red blood cells, after which isotonicity was restored with the same volume of 1.6% NaCl. After treatment, the cells were washed twice with HBSS and the tube was centrifuged at 400g for 5 min. The final concentration of cells was adjusted to 5 ϫ 10 6 cells/mL for the measurement of superoxide production by CLA-phenyl-dependent chemiluminescence (CL) and cytochrome c reduction assay or 5 ϫ 10 8 cells/mL for immunoblot assay. Zymosan A was suspended and boiled in 0.1 M Veronal buffer (pH 7.4) at a concentration of 4 mg/mL for 90 min (11) . After centrifugation at 1,900g for 10 min, 50 mg zymosan was opsonized with 5 mL healthy serum for 30 min at 37°C. Subsequently, centrifugation was performed at 1,900g for 10 min to obtain a zymosan pellet. The OZ was washed twice with HBSS and suspended at a final concentration of 20 mg/mL in HBSS and aliquots were stored at Ϫ20°C until use.
Isolated neutrophils were suspended in reaction buffer containing 10 mM HEPES (pH 7.4), 140 mM NaCl, 10 mM KCl, 0.1 mM CaCl 2 , 0.2 mM MgCl 2 , 12 mM NaHCO 3 , and 5 mM glucose. Subsequently, neutrophils were divided into three groups. The Control group was kept without any stimulation. The OZ group was stimulated with 1 mg OZ. The LϩOZ group was pretreated with 15 M lidocaine, and then the cells were stimulated with 1 mg OZ. It is reported that peak plasma lidocaine level is achieved 15 M after epidural injection of 200 mg lidocaine. Therefore, we selected 15 M as a base. A dose-dependence study was performed at final concentrations of 3.7, 7.5, and 15 M lidocaine.
Two methods were used in this study to measure superoxide production in neutrophils. One was the CL method, which is based on the light intensity when CLA-phenyl is reduced by superoxide anion (12) . CL is a useful method to monitor the time course of continuous superoxide production in neutrophils. The experiments were performed as follows. The neutrophil suspension (0.2 mL) was preincubated for 5 min at 37°C. After preincubation, CLA-phenyl was added at a final concentration of 1 M and phagocytosis was initiated with 1 mg OZ. The intensity of CL was monitored using a Niti-on Lumicounter 1000 (Chiba, Japan). We determined peak time, maximum intensity, and partial amount of CL, which are defined as elapsed time from OZ stimulation to the peak of the CL curve, maximum height and area from 2 to 7 min of CL curve, respectively. The other method uses cytochrome c reduction assay, which undergoes a color change after reduction by superoxide anion (13) . The same volume of neutrophil suspension was incubated with 80 M cytochrome c in the presence or absence of 1 mg OZ for 15 min at 37°C. After incubation, the reaction was stopped by the addition of superoxide dismutase, followed by centrifugation at 2,200g for 10 min. The absorbance of the supernatant was determined at 550 nm using a Hitachi Spectrophotometer U-3200 (Hitachi, Tokyo, Japan).
Translocation of p47 phox was detected by immunoblot assay. Neutrophils were suspended in break buffer containing 6 mM Pipes (pH 7.3), 60 mM NaCl, 1.8 mM KCl, 6% sucrose, 2.3 mM MgCl 2 , 1 M diisopropyl fluorophosphate, 1 M phenylmethylsulfonylfluoride, and 1 g/mL pepstatin, and then disrupted by sonication using a Branson Sonifier Cell Disruptor 200 (Branson, Danbury, CT). Unbroken cells and nuclei were discarded by centrifugation at 500g for 5 min at 4°C. The resulting supernatant was centrifuged at 110,000g for 30 min at 4°C using a Hitachi Ultracentrifuge 55p-72 (Tokyo, Japan). The high-speed supernatant was used as the cytosolic fraction, and the pellet was washed with break buffer and centrifuged under the same conditions. The final precipitate as the membrane fraction was resuspended in break buffer. The cytosolic and membrane fractions (30 g protein) were electrophoresed on 8% sodium dodecyl sulfate (SDS)-polyacrylamide gel, then transferred to polyvinylidene difluoride (Millipore, Bedford, MA), and blocked for 60 min with 5% nonfat milk and 0.1% Tween 20 in Tris-buffered saline (TBS-T) (pH 7.6). The primary polyclonal antibody raised against p47 phox was donated by Dr. Segal (University College, London, England) (8) , and used at a concentration of 1:1,000 in 3% nonfat milk in TBS-T. The transferred membrane was incubated with anti-p47 phox antibody for 60 min and washed 3 times with TBS-T. The second antibody probed with horseradish-conjugated goat antirabbit antibody (1:15,000) was visualized using an enhanced ECL CL detection kit.
Statistical analysis was performed by MannWhitney U-test. Data were expressed as mean Ϯ sd. The lower limit of statistical significance was set at P Ͻ 0.05.
Results
At the beginning of this study, we examined whether CLA-phenyl-dependent CL was suppressed by lidocaine, using the xanthine/xanthine oxidase system to generate superoxide in vitro. The result indicated that the CL method and superoxide generation were not affected by the addition of 15 M lidocaine (data not shown). Our finding is in agreement with a previous study (14) . Therefore, we decided to use the CL method to assess superoxide production in neutrophils.
The effects of lidocaine on 2-methyl-6-phenyl-3,7-dihydro [1,2-a] pyrazin-3-one (CLA phenyl)-dependent CL are shown in Figure 1 . No increase in CL intensity was found in control neutrophils, which were not activated by OZ. In contrast, a marked increase was revealed in CL of OZ-activated neutrophils. CL was suppressed in LϩOZ in comparison with that in OZ-activated neutrophils. Subsequently, we determined the peak time ( Fig. 2A) , the maximum intensity (Fig. 2B) , and the partial amount (Fig. 2C) . These indices are representative of the initial speed of activation, maximum activation and the partial amount of superoxide production, respectively. The CL peak in OZ-stimulated neutrophils was slightly earlier than that in LϩOZ neutrophils. The maximum count and the area under the curve representing the CL in LϩOZ neutrophils were suppressed by approximately 40% compared with those in OZ-stimulated neutrophils.
To investigate the dose-dependent effect of lidocaine, we used the cytochrome c reduction method for the determination of superoxide production. Figure 3 shows that neutrophils stimulated by OZ generated superoxide anions at a level approximately 7 times that of control cells. After pretreatment with various concentrations of lidocaine, OZ-dependent superoxide production was suppressed in a dose dependent manner.
To investigate the effect of lidocaine on the translocation of p47 phox, we subjected both the cytosolic and membrane fractions on SDS-PAGE, and then immunoblotted with polyclonal anti-p47 phox antibody. p47 phox in OZ-nonstimulated neutrophils was found only in the cytosolic fraction. After OZ-activation, p47 phox was translocated to the membrane. This translocation was suppressed by treatment with 15 M lidocaine (Fig. 4) in a dose-dependent manner (Fig. 5) .
Discussion
Neutrophils are important in the self-defense system against infection. They migrate out of blood vessels into tissues in response to chemotactic stimulating agents produced at the site of inflammation (15) . When neutrophils arrive at the site of inflammation, they attempt to phagocytose and degrade substances such as bacteria, pathogens, and remnants of damaged tissue. Neutrophils have both oxygen-dependent and independent bactericidal mechanisms (7,16). Granular elastase of neutrophils is an oxygen-independent mechanism, which directly digests bacterial proteins. In contrast, oxygen-dependent mechanisms require the superoxide anion, which is produced by NADPHoxidase. Administration of local anesthetics inhibits the function and alters the surface membrane of neutrophils (2, 3, 17) .
Reports from other investigators indicated that local anesthetics suppressed superoxide generation of neutrophils (4, 5) . These studies were performed using PMA as an activator of neutrophils. PMA activates neutrophils through interaction with the signal transduction system of protein kinase C. However, it has been indicated that stimulation of neutrophils by PMA differs from physiological stimulation. Therefore, we used OZ, a Fc receptor-mediated stimulus, to measure the production of superoxide by neutrophils. Our experiments showed that lidocaine suppressed superoxide production of human neutrophils, even when OZ was used as a neutrophil activator. The plasma level of lidocaine is affected by the site of injection, dosage, volume, and addition of a vasoconstrictor agent. After the intercostal injection of 200 mg lidocaine, the lidocaine level in plasma peaked at 25 M and remained above 15 M for more than 45 minutes, whereas levels also reached 15 M after IV, epidural, and subcutaneous vaginal injection of 200 mg lidocaine (18) . We found in this study that 15 M lidocaine suppressed superoxide production of neutrophils by approximately 40% compared with that of OZ-activated neutrophils.
Our results suggest that even therapeutic doses of lidocaine potentially suppress the superoxide production of neutrophils in plasma. Therefore, it is conceivable that a large lidocaine concentration may increase the risk of infection at the injection site or in the epidural space where lidocaine is directly administered. In fact, several reports have suggested that local anesthetics, with longterm use, have the potential to cause infections such as bacterial dermatitis or epidural abscess (1,19) . The suppressive effects of lidocaine might, however, prove to be potentially useful in the treatment of disease where neutrophils are related to the pathogenesis. It has, in fact, been reported that lidocaine led to reduced infarction size in patients with acute myocardial infarction (20) and attenuated lung injury caused by aspiration and adult respiratory distress syndrome (21, 22) . These reports prompted us to investigate the effects of lidocaine on the mechanisms of superoxide production in human neutrophils.
To elucidate the mechanisms by which lidocaine inhibits superoxide production, we used an immunoblot assay for p47 phox. Figure 4 shows that no translocation was found in control neutrophils. In contrast, lidocaine suppressed OZ-activated translocation of p47 phox. Furthermore, this suppression was dosedependent in a manner similar to the dose-dependent suppression of superoxide production we showed in the cytochrome c reduction assay. These results suggest that suppression of superoxide production by lidocaine closely matches the suppression of p47 phox translocation.
Recently, the mechanisms of the interaction between p47 phox and cytochrome b558 were partly elucidated. Shiose and Sumimoto (23) reported that both phosphorylation of p47 phox and arachidonic acid were required for the binding of p47 phox to cytochrome b558. It has also been reported that 2-hydroxymethyl-1-naphthol diacetate, an inhibitor of phospholipase D (PLD), caused a decrease of membrane-associated p47 phox in PMA-stimulated neutrophils (24) . However, it has been reported that local anesthetics, including lidocaine, inhibit activation of protein kinase C (PKC), which is thought to play important roles in p47 phox phosphorylation, phospholipase A2 (PLA 2 ), which has the ability to release arachidonic acid from cell membranes, and PMA-induced PLD activation (25) (26) (27) . These reports suggested that lidocaine inhibits PKC, PLA 2 , and PLD, resulting in inhibition of phosphorylation of p47 phox, arachidonic acid release, and the lipid signaling cascade for translocation of p47 phox.
Our results and related reports lead us to consider that the inhibitory effects of lidocaine on superoxide production in neutrophils might be caused by suppression of translocation of p47 phox from the cytosol to the cell membrane.
